Article Details

With No FDA-Approved Drugs For Relapsed AL Amyloidosis, Can Immix Biopharma's NXC ...

Retrieved on: 2025-09-28 19:52:37

Tags for this article:

Click the tags to see associated articles and topics

With No FDA-Approved Drugs For Relapsed AL Amyloidosis, Can Immix Biopharma's NXC .... View article details on hiswai:

Excerpt

Immix Biopharma will present and host institutional investor meetings at the Stifel 2025 Healthcare Conference, taking place November 11-13, 2025.

Article found on: www.rttnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo